4
Changes in Ownership
TEVA PHARMACEUTICAL INDUSTRIES LTD Filed Acc 0001209191-19-010841
Exec. VP Chief Legal Officer sold 3,926 shares at $17.74 ($69,647)
- Exec. VP Chief Legal Officer acquired 3,926 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Stark David Matthew · Exec. VP Chief Legal Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2019-02-14 | Exercise or conversion : show line 1 in the form | +3,926 | 6,900.39 | D | ||
| 2019-02-14 | Sale : show line 2 in the form | −3,926 | $17.74 | $69,647 | 2,974.39 | D |
| Open-market sales · 3,926 sh · avg $17.74 · $69,647 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2019-02-14 | Exercise or conversion : show line 3 in the form Restricted Share Units | −3,926 | 7,852 | D |
Loading xslF345X03/doc4.xml…